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Background: The risk of peri-procedural myocardial infarction (MI) during percutane-
ous coronary intervention (PCI) of chronic total occlusions (CTOs) is reported to be low,
however it may be underestimated because systematic cardiac biomarker measurement
was not performed in prior studies.
Methods: We retrospectively examined the incidence of peri-procedural MI among 325
consecutive CTO PCIs performed at our institution between 2006 and 2012. Creatine
kinase MB fraction (CK-MB) and troponin T or I was measured before PCI and after 8-12
and 18-24 hours in all patients. Myocardial infarction was defined as CK-MB increase
3x upper limit of normal.
Results: Mean age was 6410 years, 99 % or patients were men, 47% had diabetes, 26
% had prior coronary artery bypass graft surgery and 47% had prior PCI. The CTO target
vessel was the right coronary artery (56%), left anterior descending artery (21.5%),
circumflex (20.5%), and left main or bypass graft (1%). The retrograde approach was used
in 26.3% of all procedures. The technical and procedural success rates were 77.2% and
76%, respectively. The mean procedural time, fluoroscopy time, radiation dose and
contrast utilization was 14172 minutes, 4022 minutes, 4.62.4 Gray and 356146
ml, respectively. Peri-procedural MI occurred in 28 of 325 patients (8.6%). Seven of those
patients had ischemic symptoms. The prevalence of peri-procedural cardiac troponin
elevation 3x, 10x, and 20x upper limit of normal was 57%, 24% and 7.6%,
respectively. The incidence of peri-procedural MI was similar among patients with
procedural failure vs. procedural success (11.8% vs. 7.6%, p0.26), but was higher with
the retrograde compared to the antegrade approach (13.8% vs. 6.7%, p0.04).
Conclusions: Systematic measurement of cardiac biomarkers post CTO PCI demon-
strates that peri-procedural MI occurs in 8.6% of patients and is more common with the
retrograde approach.
TCT-455
Coronary Chronic Total Occlusion Revascularization: Immediate Procedural
Outcomes from a Multicenter US Registry
Dimitri Karmpaliotis1, Tesfaldet Michael2, Emmanouil Brilakis3,
Aristotelis Papayannis2, Daniel Tran4, Ben Kirkland5, Nicholas Lembo6,
Kalynych Anna7, Harold Carlson5, Subhash Banerjee8, William Lombardi9,
David Kandzari10
1PHI, Atlanta, USA, 2University of Texas Southwestern Medical Center & Dallas
VA Medical Center, Dallas, TX, 3VA North Texas Healthcare System and UT
Southwestern Medical Center, Dallas, USA, 4VA North Texas Healthcare System,
Dallas, Texas, Dallas, TX, 5PHI, College Park, GA, 6N/A, Atlanta, Georgia, 7PHI,
College Park, GA, 8UT Southwestern Medical Center and VA North Texas Health
Care System, Dallas, TX, Dallas, TX, 9Peacehealth St. Joseph Medical Center,
Bellingham, USA, 10Piedmont Heart Institute, Atlanta, USA
Background: Percutaneous coronary intervention (PCI) of chronic total occlusions
(CTOs) is a rapidly evolving area of interventional cardiology. We examined the
outcomes of CTO PCI from a multicenter United States registry.
Methods: We retrospectively examined the procedural outcomes of 1363 consecutive
CTO PCIs performed at 3 US institutions [St. Joseph Medical Center, Bellingham
Washington (n728), Piedmont Hospital, Atlanta Georgia (n361) and VA North Texas
Healthcare System, Dallas, Texas (n275)] between January 2006 and November 2011.
Results: Mean age was 6510 years, 85% or patients were men, 40% had diabetes, 37%
had prior coronary artery bypass graft surgery and 42% had prior PCI. The CTO target
vessel was the right coronary artery (55%), circumflex (23%), left anterior descending
artery (21%), and left main or bypass graft (1%). The retrograde approach was used in
34.4% of all procedures. The technical and procedural success rate was 85.5% and 84.2%,
respectively. The mean procedural time, fluoroscopy time and contrast utilization was
11463 minutes, 42 29minutes, and 296160 ml, respectively. A major procedural
complication occurred in 24 patients (1.8%): 3 patients died (1 due to intracranial
bleeding, 1 due to delayed cardiac tamponade, 1 due to coronary perforation), 5 had
Q-wave myocardial infarction, 2 donor vessel dissections (one requiring coronary bypass
graft surgery and one treated with stenting), 2 had equipment entrapment requiring coil
occlusion of a ventricular septal defect and the other requiring emergent surgery, 1 had
acute stent thrombosis, 1 had a transient ischemic attack and 10 patients had perforations
requiring pericardiocentesis or emergent surgery.
Conclusions: Among 3 high-volume US centers, CTO PCI can be performed with high
success and low complication rates, with use of the retrograde approach in approximately
one third of patients.
TCT-456
Radial Approach to CTO Re-canalisation is as Successful and Safer than
Femoral: Single centre observational study
Solomon Asgedom1, Peter Bjornstad2, Robert Patten1, Brendan McAdam1,
Richard Sheahan1, David Foley1
1Beaumont Hospital, Dublin, Ireland, 2Beaumont, Dublin, Ireland
Background: Despite increasing application of the radial route for PCI, recanalization of
chronic total occlusion has remained largely a trans-femoral procedure, to allow use of
larger catheters and achieve powerful support. We adopted the radial approach as routine
for all PCIs including CTOs starting 2007 and observed satisfactory treatment of CTOs.
In this study, we sought to compare procedural outcomes of radial versus femoral
approach to CTO reopening.
Methods: This is a single center observational study of consecutive patients who had
CTO recanalization or attempted reopening. Study patients were identified from a
prospectively maintained interventional database.Clinical background, procedure detail
and outcome were reviewed and analyzed.
Results: 162(93 radial, 69 femoral) consecutive patients had recanalization or attempted
recanalization of CTO. Mean age is 65.5 years and males constitute 84.4%. There were
no significant differences in baseline characteristics or in target artery between the two
groups. All occlusions were  6months and up to 12 years. Bilateral radial access was
used in 31.2%; unilateral radial in 66.7% and 2 cases had radial	 femoral 5F diagnostic
for contra-lateral injection. RCA was target artery in 53.0 % and 97.2 % had multi-vessel
disease. Overall success rate was 74.7% and trans-radial vs. trans-femoral was 83.9 vs.
62.3 % (P-value 0.01). The mean fluoroscopy time was 24.9 minutes and was similar for
both groups. No significant difference in contrast use and radiation dose was observed.
Access site complications were higher among trans-femoral group. One pseudo-aneurysm
and 2 major bleedings were encountered in the femoral group where as systemic and
coronary complications are similar for both group.
Conclusions: Radial approach for CTO re-canalisation did not hamper success and
actually was associated with higher success rates than femoral approach, probably thanks
to improved guide-wire and supporting micro-catheter technology during the last 5 years
covered. Lower complication rates, with similar radiation exposure and contrast use
encourage us to persist with the radial access including bilateral radial approach to CTOs
as the default strategy than double femoral
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Background: We previously reported promising outcomes after treatment of coronary
bifurcation lesions with the Tryton Side Branch Stent™ in more than 900 patients.
Surprisingly, acute coronary syndrome (ACS) as percutaneous coronary intervention
(PCI) indication did not predict for adverse outcomes compared to patients without ACS.
Therefore, we evaluated the differences in clinical outcomes between patients presenting
with stable/unstable angina, NSTEMI and STEMI.
Methods: Patients with stable/unstable angina, NSTEMI or STEMI as PCI indication
were included. One-year clinical outcomes were stratified according to indication and
reported as the composite of cardiac death and myocardial infarction (MI), clinically
indicated target vessel revascularization (TVR), definite/probable stent thrombosis (ST)
and target vessel failure (TVF; composite of any death, MI, and clinically indicated TVR).
Procedural success was defined as successful stent placement and no in-hospital TVF.
Results: We included 786 patients (79% stable/unstable angina, 14% NSTEMI, 7%
STEMI). In patients treated for STEMI, death/MI, clinically indicated TVR, and TVF
rates were higher than in patients without STEMI. However, these differences were not
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